FDA Releases Topamax Warning Citing High Risk of Cleft Palate Birth Defects: Law Firm Anapol Schwartz Launches Online Resources for Women and Expecting Mothers

Share Article

On March 4, 2011, the Food and Drug Administration (FDA) issued a news release warning the public about an increased risk of cleft palate and lip palate oral birth defects for infants born to mothers who have taken the antiepileptic drug Topamax (topiramate) and its generic forms.

Philadelphia Personal Injury Attorneys

Anapol Schwartz

Anapol Schwartz examines how Topamax has caused cleft palate, the development of cleft palate during a woman’s first trimester of pregnancy, cleft palate surgery, and the potential for meritorious Topamax lawsuits.

On March 4, 2011, the Food and Drug Administration (FDA) issued a news release warning the public about an increased risk of cleft palate and lip palate oral birth defects for infants born to mothers who have taken the antiepileptic drug Topamax (topiramate) and its generic forms.

To keep pregnant women, women who may become pregnant, as well as partners, family members, and friends of these women informed about the potential dangers of Topamax cleft palate, the Philadelphia based personal injury law firm of Anapol Schwartz is launching various online resources covering Topamax lawsuits, Topamax cleft palate, Topamax birth defect lawyers, and more.

Anapol Schwartz offers an FDA Topamax adverse event data section providing a list of reports on a case by case detailed basis, thus serving as an additional resource to those concerned about Topamax cleft palate risks. As Pennsylvania personal injury lawyers with years of experience handling pharmaceutical litigation and class action lawsuits, the legal team at Anapol Schwartz knows how vital it is for those harmed by a dangerous drug or a medical professional’s negligence to fully understand their legal rights and options as well as have easy and quick access to informative and helpful resources.

The Anapol Schwartz online resources address the fact that Topamax is prescribed to treat specific kinds of seizures for people with epilepsy and is also used to prevent migraine headaches. The resources also emphasize that a person taking Topamax should not suddenly stop taking the drug, even if pregnant, until discussing the matter with a health care professional. Serious problems can be caused by immediately stopping Topamax intake. In addition, failing to treat epilepsy during pregnancy can be dangerous for a woman and her developing baby.

The Topamax oral birth defect resources on Anapol Schwartz websites have been developed specifically for women who are or have taken Topamax and have given birth to a child with cleft palate, are currently pregnant, or may become pregnant. The Topamax web pages highlight the many concerns surrounding epilepsy, seizures, migraine headaches, cleft lip, and cleft palate in relation to Topamax and women. Anapol Schwartz examines how Topamax has caused cleft palate, the development of cleft palate during a woman’s first trimester of pregnancy, cleft palate surgery, and the potential for meritorious Topamax lawsuits.

The Topamax attorneys at Anapol Schwartz are available not only to assess the details surrounding a specific cleft palate birth defect in relation to medical professional negligence or drug manufacturer liability, but are also making it a priority to release new information about Topamax as it is announced. Since being founded in 1977 and growing to have over 30 attorneys, the Philadelphia plaintiff’s law firm of Anapol Schwartz continues to obtain successful case results for its clients.

# # #

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Michael Monheit
Visit website